Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a choline compound studied in clinical trials for memory, attention, and physical performance, with the strongest evidence coming from research in people with Alzheimer's disease, vascular dementia, and post-stroke cognitive decline, where doses around 1,200 mg daily improved cognitive test scores. Smaller trials in healthy adults suggest possible short-term gains in power output, reaction time, and focus, though results are mixed, sample sizes are small, and benefits for healthy memory remain unproven. Dosing, timing, form, and side effects such as headache, nausea, insomnia, and heartburn all matter, and emerging data has raised questions about stroke risk with long-term use, so there are several important factors to consider before starting it. See below for the full breakdown of trial findings, dosing details, and safety cautions.
If you are considering Alpha-GPC because of brain fog, forgetfulness, low energy, or trouble concentrating, it is worth understanding what is actually driving those symptoms, since causes range from poor sleep and thyroid problems to nutrient deficiencies, medication effects, anxiety, and early cognitive change. Take a free, instant, online symptom check to get personalized insight into your symptoms and clear guidance on what to do next.
Last reviewed for medical accuracy: 09/28/2026
Alpha-GPC (alpha-glycerophosphocholine) is a naturally occurring choline compound found in the brain. It’s often used as a dietary supplement to support cognitive health and physical performance. Research into alpha GPC benefits has grown in recent years, with several randomized controlled trials (RCTs) suggesting potential improvements in memory, attention, and power output. Below, we summarize what credible trials show, explain how alpha-GPC works, and outline safety, dosage, and next steps.
Multiple RCTs have evaluated alpha GPC benefits in adults with cognitive decline:
Giacobini et al. (1991)
Meta-Analysis (Zhang et al., 2017)
Ritchie et al. (2008)
Stough et al. (2015)
Alpha GPC benefits extend beyond cognition; some studies highlight physical performance gains.
Ziegenfuss et al. (2008)
Momaya et al. (2015)
In well-designed trials, side effects were mild and infrequent:
No serious adverse events were reported in healthy adults or patients with dementia at standard doses.
Alpha GPC benefits appear promising for memory support, attention, and exercise power output. However, individual responses differ, and supplements aren’t a substitute for medical care. If you’re considering alpha GPC:
If you have ongoing concerns or experience serious symptoms—such as severe headaches, confusion, or chest pain—speak to a doctor right away. For non-urgent advice on symptoms, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Research on alpha GPC benefits shows consistent evidence for supporting memory and attention in both clinical and healthy populations, with additional gains in physical power. Side effects are generally mild, but long-term data are still emerging. Before starting any new supplement, consult your healthcare provider—especially if you have serious or life-threatening conditions. They can help you weigh the potential rewards against any risks and determine the right dosage for your needs.
(References)
* Govoni S, Lucchi L, Battaini F, Trabucchi M. Protein kinase C increase in rat brain cortical membranes may be promoted by cognition enhancing drugs. Life Sci. 1992;50(16):PL125-8. doi: 10.1016/0024-3205(92)90465-2. PMID: 1552828.
* Harrison KA, Davies SS, Marathe GK, McIntyre T, Prescott S, Reddy KM, Falck JR, Murphy RC. Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques. J Mass Spectrom. 2000 Feb;35(2):224-36. doi: 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G. PMID: 10679985.
* Kondrat'ev AN, Lesina SS, Kondrat'eva EA, Nazarov PV. [Experience with gliatilin treatment of patients with intracranial neoplasia]. Vopr Onkol. 2006;52(2):203-4. PMID: 17195650.
* Shmyrev VI, Kryzhanovskiĭ SM. [The domestic drug cereton in the treatment of patients in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(12):53-6. PMID: 19253468.
* Ismagilov MF, Vasilevskaia OV, Gaĭfutdinov RT, Strakhova TM, Kuz'mina IA. [Efficacy of cereton in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(3):35-6. PMID: 19365389.
* Stulin ID, Musin RS, Solonskiĭ DS. [Choline alphoscerate (ceretone) in the treatment of patients with chronic cerebral ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(7):87-9. PMID: 19708279.
* Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results. J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7. PMID: 22959283.
* Putilina MV. [Combined therapy of cerebrovascular disorders with neuroprotectors]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11):58-63. doi: 10.17116/jnevro201611611158-63. PMID: 28091502.
* Jeanne Dit Fouque K, Ramirez CE, Lewis RL, Koelmel JP, Garrett TJ, Yost RA, Fernandez-Lima F. Effective Liquid Chromatography-Trapped Ion Mobility Spectrometry-Mass Spectrometry Separation of Isomeric Lipid Species. Anal Chem. 2019 Apr 16;91(8):5021-5027. doi: 10.1021/acs.analchem.8b04979. Epub 2019 Apr 4. PMID: 30896930.
* Shishkova VN, Dranitsina BG. [Postcovid cognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(12):45-49. doi: 10.17116/jnevro202212212145. PMID: 36537630.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.